Cargando…
Flibanserin: Approval of a controversial drug for a controversial disorder
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623637/ https://www.ncbi.nlm.nih.gov/pubmed/26600572 http://dx.doi.org/10.4103/0019-5545.166630 |
| _version_ | 1782397710896201728 |
|---|---|
| author | Sathyanarayana Rao, T. S. Andrade, Chittaranjan |
| author_facet | Sathyanarayana Rao, T. S. Andrade, Chittaranjan |
| author_sort | Sathyanarayana Rao, T. S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4623637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46236372015-11-23 Flibanserin: Approval of a controversial drug for a controversial disorder Sathyanarayana Rao, T. S. Andrade, Chittaranjan Indian J Psychiatry Editorial Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4623637/ /pubmed/26600572 http://dx.doi.org/10.4103/0019-5545.166630 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Sathyanarayana Rao, T. S. Andrade, Chittaranjan Flibanserin: Approval of a controversial drug for a controversial disorder |
| title | Flibanserin: Approval of a controversial drug for a controversial disorder |
| title_full | Flibanserin: Approval of a controversial drug for a controversial disorder |
| title_fullStr | Flibanserin: Approval of a controversial drug for a controversial disorder |
| title_full_unstemmed | Flibanserin: Approval of a controversial drug for a controversial disorder |
| title_short | Flibanserin: Approval of a controversial drug for a controversial disorder |
| title_sort | flibanserin: approval of a controversial drug for a controversial disorder |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623637/ https://www.ncbi.nlm.nih.gov/pubmed/26600572 http://dx.doi.org/10.4103/0019-5545.166630 |
| work_keys_str_mv | AT sathyanarayanaraots flibanserinapprovalofacontroversialdrugforacontroversialdisorder AT andradechittaranjan flibanserinapprovalofacontroversialdrugforacontroversialdisorder |